Machine Learning

A new three-way partnership aims to create a seamless, high-tech "one-stop shop" for MICE clients at a luxury Fort Canning venue.

A new gene therapy that reprograms cancer cells into immune activators shows major promise, blending personalized treatment with off-the-shelf convenience.

With a $50M state investment and a new White House directive, Texas is pioneering ibogaine research. But can it overcome the drug's risks and legal hurdles?

A $2.5M gift honors a legacy and empowers a top scientist to develop imaging tech that could revolutionize how we diagnose and treat blindness.

New data reveals a novel cancer drug shrinks brain metastases in over half of small cell lung cancer patients, offering hope where options are scarce.

A new platform watches individual tumor cells to link behavior with biology, offering a powerful tool against treatment resistance in cancers like glioblastoma.

Genomic Prediction reappoints its founding CEO, Laurent Tellier, signaling a push for innovation amid ethical debates and questions about its market standing.

Presented at AACR 2026, first-in-class antibody IMT-009 shows clinical benefit in tough cancers, potentially paving the way for a new precision therapy.

New data on ATX-295 reveals a potent attack on unstable tumors, guided by an AI biomarker that could change how we select patients for treatment.

Newcomer Capital-FORCE makes a strategic entry into the competitive ETF space by acquiring two established IBD-branded funds from Innovator.

Interim study results suggest a common food product may significantly enhance the effectiveness of modern cancer treatments, heralding a new era of care.

A surprise $5 million pledge for glaucoma research highlights a gala honoring philanthropist Daria Barry, patient advocate Hillary Golden, and music icon Nile Rodgers.

The $4.1 trillion U.S. Latino economy is being leveraged to tackle energy costs, infrastructure challenges, and the soaring demands of AI technology.

For the first time, a major regulatory body has approved a drug name created by AI, signaling a new era for the highly regulated pharmaceutical industry.

The era of monolithic chips is ending. A new wave of system-level design using advanced packaging is solving AI's biggest power and bandwidth challenges.

Rove launches three new potent pre-roll strains for 4/20, tapping into a booming market where infused products and high-potency cannabis now dominate.

A new integration for Quantum's CatDV platform ditches AI hype for deterministic data, promising to end manual logging for teams like the Miami HEAT.

A new partnership lets you buy Meta's AI glasses with pre-tax health funds, blurring the lines between consumer tech, health spending, and personal privacy.

At AACR 2026, CREATE Medicines debuts its RetroT platform, an all-RNA system for stable gene delivery that avoids viral vectors and reshapes cell therapy.

Hofstra University pioneers eco-friendly turf tech, elevating athlete safety and performance in a major upgrade to its NCAA Division I facilities.